| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 |
| NetGPI | no | yes: 0, no: 10 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005737 | cytoplasm | 2 | 1 |
| GO:0031974 | membrane-enclosed lumen | 2 | 1 |
| GO:0031981 | nuclear lumen | 5 | 1 |
| GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
| GO:0043233 | organelle lumen | 3 | 1 |
| GO:0070013 | intracellular organelle lumen | 4 | 1 |
| GO:0097014 | ciliary plasm | 5 | 1 |
| GO:0099568 | cytoplasmic region | 3 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 3 |
| GO:0005929 | cilium | 4 | 2 |
| GO:0042995 | cell projection | 2 | 2 |
| GO:0043226 | organelle | 2 | 2 |
| GO:0043227 | membrane-bounded organelle | 3 | 2 |
| GO:0120025 | plasma membrane bounded cell projection | 3 | 2 |
Related structures:
AlphaFold database: E9AZI8
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
| GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
| GO:0006747 | FAD biosynthetic process | 7 | 1 |
| GO:0006753 | nucleoside phosphate metabolic process | 4 | 1 |
| GO:0006793 | phosphorus metabolic process | 3 | 1 |
| GO:0006796 | phosphate-containing compound metabolic process | 4 | 1 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
| GO:0008152 | metabolic process | 1 | 1 |
| GO:0009058 | biosynthetic process | 2 | 1 |
| GO:0009117 | nucleotide metabolic process | 5 | 1 |
| GO:0009165 | nucleotide biosynthetic process | 6 | 1 |
| GO:0009987 | cellular process | 1 | 1 |
| GO:0018130 | heterocycle biosynthetic process | 4 | 1 |
| GO:0019438 | aromatic compound biosynthetic process | 4 | 1 |
| GO:0019637 | organophosphate metabolic process | 3 | 1 |
| GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
| GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 1 |
| GO:0042726 | flavin-containing compound metabolic process | 4 | 1 |
| GO:0042727 | flavin-containing compound biosynthetic process | 5 | 1 |
| GO:0044237 | cellular metabolic process | 2 | 1 |
| GO:0044238 | primary metabolic process | 2 | 1 |
| GO:0044249 | cellular biosynthetic process | 3 | 1 |
| GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 1 |
| GO:0044281 | small molecule metabolic process | 2 | 1 |
| GO:0046443 | FAD metabolic process | 6 | 1 |
| GO:0046483 | heterocycle metabolic process | 3 | 1 |
| GO:0055086 | nucleobase-containing small molecule metabolic process | 3 | 1 |
| GO:0071704 | organic substance metabolic process | 2 | 1 |
| GO:0072387 | flavin adenine dinucleotide metabolic process | 5 | 1 |
| GO:0072388 | flavin adenine dinucleotide biosynthetic process | 6 | 1 |
| GO:0090407 | organophosphate biosynthetic process | 4 | 1 |
| GO:1901293 | nucleoside phosphate biosynthetic process | 5 | 1 |
| GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
| GO:1901362 | organic cyclic compound biosynthetic process | 4 | 1 |
| GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
| GO:1901566 | organonitrogen compound biosynthetic process | 4 | 1 |
| GO:1901576 | organic substance biosynthetic process | 3 | 1 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 11 |
| GO:0003919 | FMN adenylyltransferase activity | 6 | 1 |
| GO:0016740 | transferase activity | 2 | 1 |
| GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 1 |
| GO:0016779 | nucleotidyltransferase activity | 4 | 1 |
| GO:0070566 | adenylyltransferase activity | 5 | 1 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 117 | 119 | PF00675 | 0.245 |
| CLV_NRD_NRD_1 | 46 | 48 | PF00675 | 0.593 |
| CLV_NRD_NRD_1 | 71 | 73 | PF00675 | 0.601 |
| CLV_PCSK_KEX2_1 | 190 | 192 | PF00082 | 0.592 |
| CLV_PCSK_KEX2_1 | 21 | 23 | PF00082 | 0.535 |
| CLV_PCSK_KEX2_1 | 46 | 48 | PF00082 | 0.593 |
| CLV_PCSK_PC1ET2_1 | 190 | 192 | PF00082 | 0.457 |
| CLV_PCSK_PC1ET2_1 | 21 | 23 | PF00082 | 0.535 |
| CLV_PCSK_SKI1_1 | 111 | 115 | PF00082 | 0.286 |
| CLV_PCSK_SKI1_1 | 17 | 21 | PF00082 | 0.474 |
| CLV_PCSK_SKI1_1 | 47 | 51 | PF00082 | 0.602 |
| CLV_Separin_Metazoa | 43 | 47 | PF03568 | 0.610 |
| DOC_MAPK_MEF2A_6 | 107 | 114 | PF00069 | 0.478 |
| DOC_PP1_RVXF_1 | 109 | 115 | PF00149 | 0.520 |
| DOC_USP7_MATH_1 | 165 | 169 | PF00917 | 0.520 |
| DOC_USP7_UBL2_3 | 103 | 107 | PF12436 | 0.370 |
| DOC_USP7_UBL2_3 | 17 | 21 | PF12436 | 0.339 |
| DOC_WW_Pin1_4 | 132 | 137 | PF00397 | 0.539 |
| LIG_14-3-3_CanoR_1 | 118 | 122 | PF00244 | 0.400 |
| LIG_14-3-3_CanoR_1 | 46 | 52 | PF00244 | 0.604 |
| LIG_14-3-3_CanoR_1 | 8 | 16 | PF00244 | 0.565 |
| LIG_14-3-3_CterR_2 | 212 | 215 | PF00244 | 0.686 |
| LIG_Actin_WH2_2 | 97 | 113 | PF00022 | 0.367 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.544 |
| LIG_FHA_1 | 48 | 54 | PF00498 | 0.597 |
| LIG_LIR_Gen_1 | 171 | 181 | PF02991 | 0.518 |
| LIG_LIR_Gen_1 | 66 | 76 | PF02991 | 0.523 |
| LIG_LIR_Nem_3 | 135 | 141 | PF02991 | 0.487 |
| LIG_LIR_Nem_3 | 171 | 177 | PF02991 | 0.541 |
| LIG_LIR_Nem_3 | 18 | 23 | PF02991 | 0.556 |
| LIG_LIR_Nem_3 | 66 | 71 | PF02991 | 0.549 |
| LIG_SH2_CRK | 158 | 162 | PF00017 | 0.449 |
| LIG_SH2_CRK | 174 | 178 | PF00017 | 0.383 |
| LIG_SH2_NCK_1 | 174 | 178 | PF00017 | 0.529 |
| LIG_SH2_SRC | 23 | 26 | PF00017 | 0.538 |
| LIG_SH2_STAP1 | 158 | 162 | PF00017 | 0.484 |
| LIG_SH2_STAT5 | 14 | 17 | PF00017 | 0.442 |
| LIG_SH2_STAT5 | 158 | 161 | PF00017 | 0.440 |
| LIG_SH3_1 | 133 | 139 | PF00018 | 0.515 |
| LIG_SH3_3 | 133 | 139 | PF00018 | 0.526 |
| LIG_SH3_3 | 46 | 52 | PF00018 | 0.665 |
| LIG_UBA3_1 | 15 | 21 | PF00899 | 0.517 |
| MOD_CK1_1 | 172 | 178 | PF00069 | 0.499 |
| MOD_CK1_1 | 180 | 186 | PF00069 | 0.551 |
| MOD_CK2_1 | 165 | 171 | PF00069 | 0.526 |
| MOD_GlcNHglycan | 171 | 174 | PF01048 | 0.315 |
| MOD_GSK3_1 | 165 | 172 | PF00069 | 0.509 |
| MOD_GSK3_1 | 173 | 180 | PF00069 | 0.451 |
| MOD_N-GLC_1 | 9 | 14 | PF02516 | 0.512 |
| MOD_NEK2_1 | 114 | 119 | PF00069 | 0.389 |
| MOD_NEK2_1 | 148 | 153 | PF00069 | 0.512 |
| MOD_NEK2_1 | 169 | 174 | PF00069 | 0.538 |
| MOD_NEK2_1 | 97 | 102 | PF00069 | 0.553 |
| MOD_NEK2_2 | 165 | 170 | PF00069 | 0.520 |
| MOD_PIKK_1 | 91 | 97 | PF00454 | 0.586 |
| MOD_PKA_2 | 117 | 123 | PF00069 | 0.368 |
| MOD_Plk_4 | 165 | 171 | PF00069 | 0.520 |
| MOD_Plk_4 | 35 | 41 | PF00069 | 0.484 |
| MOD_Plk_4 | 97 | 103 | PF00069 | 0.626 |
| MOD_ProDKin_1 | 132 | 138 | PF00069 | 0.539 |
| TRG_AP2beta_CARGO_1 | 66 | 75 | PF09066 | 0.617 |
| TRG_DiLeu_BaLyEn_6 | 184 | 189 | PF01217 | 0.596 |
| TRG_ENDOCYTIC_2 | 158 | 161 | PF00928 | 0.455 |
| TRG_ENDOCYTIC_2 | 174 | 177 | PF00928 | 0.361 |
| TRG_ER_diArg_1 | 45 | 47 | PF00400 | 0.591 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1I7C6 | Leptomonas seymouri | 58% | 86% |
| A0A0S4IUQ2 | Bodo saltans | 40% | 93% |
| A0A1X0NVD4 | Trypanosomatidae | 46% | 66% |
| A0A3S7X154 | Leishmania donovani | 94% | 100% |
| A4HG68 | Leishmania braziliensis | 87% | 100% |
| A4I3B1 | Leishmania infantum | 94% | 100% |
| D0A7S9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 67% |
| O74841 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 32% | 81% |
| P38913 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 28% | 70% |
| Q4Q8P3 | Leishmania major | 94% | 100% |
| V5B9Z2 | Trypanosoma cruzi | 44% | 67% |